MPV and NLR as Predictors of SBP Diagnosis
Mean Platelet Volume (MPV) and Neutrophil to Lymphocyte Ratio (NLR) as Predictors of Spontaneous Bacterial Peritonitis in Cirrhotic Patients
1 other identifier
observational
332
1 country
1
Brief Summary
The aim of the study is to investigate the clinical utility of mean platelet volume (MPV) and neutrophil to lymphocyte ratio (NLR) as diagnostic markers for spontaneous bacterial peritonitis (SBP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedFirst Submitted
Initial submission to the registry
February 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedJanuary 23, 2023
January 1, 2023
2.1 years
February 25, 2021
January 20, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The utility of MPV as non-invasive predictor of SBP
It will be measured from CBC
1 year
The utility of NLR as non-invasive predictor of SBP
It will be measured from CBC
1 year
Study Arms (2)
Group 1
Ascetic patients without spontaneous bacterial peritonitis
Group 2
Ascetic patients with spontaneous bacterial peritonitis
Interventions
MPV and NLR are easily accessible and inexpensive tests
Eligibility Criteria
Patients with ascites due to decompensated liver cirrhosis admitted at the inpatient section of Tropical Medicine and Gastroenterology Department, Sohag University Hospital.
You may qualify if:
- Decompensated liver cirrhosis ascetic patients.
You may not qualify if:
- Immunocompromised patients.
- Patients who had received antibiotics before hospital admission.
- Patients on anticoagulant medications, NSAIDs, or oral contraceptive drugs.
- Patients with heart failure, diabetes mellitus, hypertension, hyperlipidemia, peripheral vascular disease, hematological disorders, and neoplastic disorders and patients with clinically overt hypothyroidism or hyperthyroidism or with clinically and laboratory-evident autoimmune diseases.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag Faculty of Medicine
Sohag, 82524, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 25, 2021
First Posted
March 1, 2021
Study Start
April 1, 2020
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
January 23, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share